HomeDiscoveryPubblicazioniPubblicazioni 2018

Pubblicazioni 2018

2018

 

A fast and straightforward procedure for vault nanoparticle purification and the characterization of its endocytic uptake.
Galbiati E, Avvakumova S, La Rocca A, Pozzi M, Messali S, Magnaghi P, Colombo M, Prosperi D, Tortora P
Biochim Biophys Acta Gen Subj. 2018 Jul 20;1862(10):2254-2260

PATRI, a Genomics Data Integration Tool for Biomarker Discovery.
Ukmar G, Melloni GEM, Raddrizzani L, Rossi P, Di Bella S, Pirchio MR, Vescovi M, Leone A, Callari M, Cesarini M, Somaschini A, Della Vedova G, Daidone MG, Pettenella M, Isacchi A, Bosotti
Biomed Res Int. 2018 Jun 28;2018:2012078

Cord blood-derived cytokine-induced killer cells combined with blinatumomab as a therapeutic strategy for CD19+ tumors.
Golay J, Martinelli S, Alzani R, Cribioli S, Albanese C, Gotti E, Pasini B, Mazzanti B, Saccardi R, Rambaldi A, Introna M.
Cytotherapy. 2018 Aug;20(8):1077-1088

Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin-Targeted Conjugate.
Raposo Moreira Dias A, Pina A, Dean A, Lerchen HG, Caruso M, Gasparri F, Fraietta I, Troiani S, Arosio D, Belvisi L, Pignataro L, Dal Corso A, Gennari C.,
Chemistry. 2018 Nov 19

Poly(ethylene glycol)-alendronate coated nanoparticles for magnetic resonance imaging of lymph nodes.
Bisso S, Degrassi A, Brambilla D, Leroux JC.
J Drug Target. 2018 Dec 4:1-11

miRandola 2017: a curated knowledge base of non-invasive biomarkers.
Russo F, Di Bella S, Vannini F, Berti G, Scoyni F, Cook HV, Santos A, Nigita G, Bonnici V, Laganà A, Geraci F, Pulvirenti A, Giugno R, De Masi F, Belling K, Jensen LJ, Brunak SR, Pellegrini M, Ferro A
Nucleic Acids Res (2018), 46(D1), D354-D359
View abstract on PubMed

Afatinib is a new therapeutic approach in chordoma with a unique ability to target EGFR and Brachyury.
Magnaghi P, Salom B, Cozzi L, Amboldi N, Ballinari D, Tamborini E, Gasparri F, Montagnoli A, Raddrizzani L, Somaschini A, Bosotti R, Orrenius C, Bozzi F, Pilotti S, Galvani A, Sommer J, Stacchiotti S, Isacchi A
Mol Cancer Ther (2018), 17(3), 603-613
View abstract on PubMed

Phase I dose escalation study of NMS-1286937, an orally available Polo-Like Kinase 1 inhibitor, in patients with advanced or metastatic solid tumors
Weiss GJ, Jameson G, Von Hoff DD, Valsasina B, Davite C, Di Giulio C, Fiorentini F, Alzani R, Carpinelli P, Di Sanzo A, Galvani A, Isacchi A, Ramanathan RK
Invest New Drugs (2018), 36(1), 85-95
View abstract on PubMed